Peonidin 3-glucoside inhibits lung cancer metastasis by downregulation of proteinases activities and MAPK pathway

Nutrition and Cancer

Volumn 62, Issue 4, 2010, Pages 505-516

  Ho, Mao Lin ^a   Chen, Pei Ni ^a   Chu, Shu Chen ^b   Kuo, Dong Yih ^a   Kuo, Wu Hsien ^b,c   Chen, Jia Yuh ^d   Hsieh, Yih Shou ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PEONIDIN 3 GLUCOSIDE; PROTEINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VIVO STUDY; LEWIS CARCINOMA; LUNG CARCINOMA; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTHOCYANINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, LEWIS LUNG; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCOSIDES; HUMANS; LUNG NEOPLASMS; MAP KINASE KINASE 1; MATRIX METALLOPROTEINASES, SECRETED; MICE; NEOPLASM TRANSPLANTATION; ORYZA SATIVA; PHOSPHORYLATION; RNA, MESSENGER; SEEDS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77951995556     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903441261     Document Type: Article

References (40)

1. Bermudez-Soto MJ, Larrosa M, Garcia-Cantalejo JM, Espin JC, Tomas-Barberan FA, et al.: Up-regulation of tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 in human colon cancer Caco-2 cells following repetitive exposure to dietary levels of a polyphenol-rich chokeberry juice. J Nutr Biochem 18, 259-271, 2007.
2. Ramos S: Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18, 427-442, 2007.
3. Lechner JF, Reen RK, Dombkowski AA, Cukovic D, Salagrama S, et al.: Effects of a black raspberry diet on gene expression in the rat esophagus. Nutr Cancer 60, 61-69, 2008.
4. Choi EH, Chang HJ, Cho JY, and Chun HS: Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities. Food Chem Toxicol 45, 1873-1881, 2007.
5. Shih PH, Yeh CT, and Yen GC: Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells. Food Chem Toxicol 43, 1557-1566, 2005.
6. McDougall GJ, Ross HA, Ikeji M, and Stewart D: Berry extracts exert different antiproliferative effects against cervical and colon cancer cells grown in vitro. J Agric Food Chem 56, 3016-3023, 2008.
7. Ling WH, Cheng QX, Ma J, and Wang T: Red and black rice decrease atherosclerotic plaque formation and increase antioxidant status in rabbits. J Nutr 131, 1421-1426, 2001
8. Hu C, Zawistowski J, Ling W, and Kitts DD: Black rice (Oryza sativa L. indica) pigmented fraction suppresses both reactive oxygen species and nitric oxide in chemical and biological model systems. J Agric Food Chem 51, 5271-5277, 2003.
9. Hyun JW and Chung HS: Cyanidin and malvidin from Oryza sativa cv. Heugjinjubyeo mediate cytotoxicity against human monocytic leukemia cells by arrest of G (2)/M phase and induction of apoptosis. J Agric Food Chem 52, 2213-2217, 2004.
10. Ichikawa H, Ichiyanagi T, Xu B, Yoshii Y, Nakajima M, et al.: Antioxidant activity of anthocyanin extract from purple black rice. J Med Food 4, 211-218, 2001.
11. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, et al.: Cancer statistics, 2005. CA Cancer J Clin 55, 10-30, 2005.
12. Tang JM, He QY, Guo RX, and Chang XJ: Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Lung Cancer 51, 181-191, 2006.
13. Chu CS, Xue B, Tu C, Feng ZH, Shi YH, et al.: NRAGE suppresses metastasis of melanoma and pancreatic cancer in vitro and in vivo. Cancer Lett 250, 268-275, 2007.
14. Sahai E: Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15, 87-96, 2005.
15. Nagase H and Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 274, 21491-21494, 1999.
16. Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, et al.: Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 7, 2396-2404, 2001.
17. Park IK, Kim BJ, Goh YJ, Lyu MA, Park CG, et al.: Co-expression of urokinase-type plasminogen activator and its receptor in human gastriccancer cell lines correlates with their invasiveness and tumorigenicity. Int J Cancer 71, 867-873, 1997.
18. Chen PN, Chu SC, Chiou HL, Chiang CL, Yang SF, et al.: Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr Cancer 53, 232-243, 2005.
19. Chen PN, Hsieh YS, Chiou HL, and Chu SC: Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem Biol Interact 156, 141-150, 2005.
20. Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, and Patierno SR: Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 60, 4629-4637, 2000.
21. Chen PN, Kuo WH, Chiang CL, Chiou HL, Hsieh YS, et al.: Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression. Chem Biol Interact 163, 218-229, 2006.
22. Guan X, Chen L, Wang J, Geng H, Chu X, et al.: Mutations of phosphorylation sites Ser10 and Thr187 of p27Kip1 abolish cytoplasmic redistribution but do not abrogate G0/1 phase arrest in the HepG2 cell line. Biochem Biophys Res Commun 347, 601-607, 2006.
23. Ho Eand Ames BN: Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci USA 99, 16770-16775, 2002.
24. Sigounas G, Sallah S, and Sigounas VY: Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model. Cancer Lett 214, 171-179, 2004.
25. Wang J, Miao LJ, Wu YM, Wu YJ, and Wang XC: Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer. Ai Zheng 25, 69-72, 2006.
26. Kuhnau J: The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24, 117-191, 1976.
27. Rao JS: Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3, 489-501, 2003.
28. Stetler-Stevenson WG: Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103, 1237-1241, 1999.
29. Itoh Y and Nagase H: Matrix metalloproteinases in cancer. Essays Biochem 38, 21-36, 2002.
30. Duffy MJ and Duggan C: The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer. Clin Biochem 37, 541-548, 2004.
31. Kim D, Kim S, Koh H, Yoon SO, Chung AS, et al.: Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. Faseb J 15, 1953-1962, 2001.
32. Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR, et al.: Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochem J 392, 249-261, 2005.
33. Westermarck J and Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 13, 781-792, 1999.
34. Hsu YL, Kuo PL, Cho CY, Ni WC, Tzeng TF, et al.: Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway. Food Chem Toxicol 45, 1249-1257, 2007.
35. Bahassiel M, Karyala S, Tomlinson CR, Sartor MA, Medvedovic M, et al.: Critical regulation of genes for tumor cell migration by AP-1. Clin Exp Metastasis 21, 293-304, 2004.
36. De Martin R, Hoeth M, Hofer-Warbinek R, and Schmid JA: The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 20, E83-E88, 2000.
37. Baldwin AS Jr: Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107, 3-6, 2001.
38. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270, 16483-16486, 1995.
39. Kelloff GJ: Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res 78, 199-334, 2000.
40. Tyagi AK, Agarwal C, Chan DC, and Agarwal R: Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncol Rep 11, 493-499, 2004.